Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women.
Primary Purpose
Hot Flashes, Menopause
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Omega 3 fatty acid vitamins
Placebo capsules
Sponsored by
About this trial
This is an interventional treatment trial for Hot Flashes focused on measuring Hot flashes, Menopause, Omega 3 fatty Acids
Eligibility Criteria
Inclusion Criteria:
- Post menopausal females (no periods for over 6 months)
- Documented Serum FSH level>20
- Positive urine FSH test
- Hot flashes, on average five a day
- A 2 week pre study washout period of exclusion criteria
Exclusion Criteria:
- No EPT/ET
- OTC supplements: ex; soy, black cohosh, flax, bellergal, primrose oil, vitamin E, red clover
- Excessive smoking > 1ppd
- Anti seizure medications
- Clonidine
- Effexor
- More than 2 servings of fish per week
Sites / Locations
- Christiana Care Health Systems
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
1
2
Arm Description
Omega 3 vitamin supplements
Placebo capsule
Outcomes
Primary Outcome Measures
The decrease in the severity in hot flashes.
Secondary Outcome Measures
Improvement in lipid profile
Full Information
NCT ID
NCT00599456
First Posted
January 11, 2008
Last Updated
May 9, 2017
Sponsor
Christiana Care Health Services
1. Study Identification
Unique Protocol Identification Number
NCT00599456
Brief Title
Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women.
Official Title
A Placebo Controlled Double Blinded Prospective Study to Investigate the Usefulness of Omega 3 Fatty Acids in the Relief of Vasomotor Symptoms of Menopausal Women
Study Type
Interventional
2. Study Status
Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
September 2007 (undefined)
Primary Completion Date
September 2009 (Actual)
Study Completion Date
September 2009 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Christiana Care Health Services
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Hot flashes can be a disturbing symptom of menopause. Prescription medications are commonly used for symptom relief. Several non-prescription therapies are under investigation. This study will examine the use of omega-3 (fish oil) supplements to see if it helps relieve hot flashes and therefore improve the quality of life.
Study Hypotheses:
Menopausal women who take Omega 3 vitamins(fish oils)will show improvement in the severity of their hot flashes.In addition women who take Omega 3 supplements will show improvement in their lipid profiles.
Detailed Description
This study requires you to have blood drawn twice, record your hot flashes for a total of 3 weeks, and to take a product every day for 12 weeks. It will also entail 4 visits and up to 4 telephone contacts. The information you provide will be maintained in a database accessible only to the primary investigator and research team. You will be assigned a code number for your blood work and all other information. The key to this code will be maintained in this database.
Overall 60-100 women will be recruited for this study locally. During the course of the study you will get overall two blood draws amounting to up to a teaspoon for measurement of your cholesterol and fat levels.
This project consists of three phases.
Phase I
We will ask you questions about your medical history and your health. You will then be asked to provide a urine sample which will be used to confirm your menopausal status with a FSH level. You will be requested to keep a record of your hot flashes for one week using a symptom diary. Upon completion of the diary, you will return to the study site. If you qualify for participation, you will have blood work done to measure your cholesterol and other fat levels through a lipid panel. You will be provided with these results free of charge at the conclusion of the study.
Phase 2
You will receive the study medication. Half of the participants will receive the actual product we are investigating and half will receive a placebo (inactive/dummy pill). Neither you nor the investigators will not know which one you are given until the end of the study. During the 4th and 12th weeks, you will be asked to keep a diary (similar to the first one) of your hot flashes.
Phase 3
At the end of the 12 week study period, you will return to the study center. The second blood draw will be done to monitor any changes. This will conclude your participation. You will be sent a copy of your cholesterol profiles and FSH levels approximately 2 weeks after you complete the study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hot Flashes, Menopause
Keywords
Hot flashes, Menopause, Omega 3 fatty Acids
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Omega 3 vitamin supplements
Arm Title
2
Arm Type
Placebo Comparator
Arm Description
Placebo capsule
Intervention Type
Dietary Supplement
Intervention Name(s)
Omega 3 fatty acid vitamins
Intervention Description
Omega 3 fatty acid vitamins, 2 capsules, by mouth, daily, for 3 months
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo capsules
Intervention Description
Placebo capsules,2 capsules, by mouth, daily for 3 months
Primary Outcome Measure Information:
Title
The decrease in the severity in hot flashes.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Improvement in lipid profile
Time Frame
3 months
10. Eligibility
Sex
Female
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Post menopausal females (no periods for over 6 months)
Documented Serum FSH level>20
Positive urine FSH test
Hot flashes, on average five a day
A 2 week pre study washout period of exclusion criteria
Exclusion Criteria:
No EPT/ET
OTC supplements: ex; soy, black cohosh, flax, bellergal, primrose oil, vitamin E, red clover
Excessive smoking > 1ppd
Anti seizure medications
Clonidine
Effexor
More than 2 servings of fish per week
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Parastoo Farhady, MD
Organizational Affiliation
Chrisitiana care Health Systems
Official's Role
Principal Investigator
Facility Information:
Facility Name
Christiana Care Health Systems
City
Newark
State/Province
Delaware
ZIP/Postal Code
19718
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women.
We'll reach out to this number within 24 hrs